Please ensure Javascript is enabled for purposes of website accessibility

Are CVS and Walgreens in Trouble if Amazon Enters the Retail Pharmacy Market?

By Keith Speights and Brian Orelli, PhD - Updated Jun 22, 2021 at 4:33PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's definitely not good news for the big pharmacy retailers.

Amazon (AMZN -0.26%) already has jumped into the online pharmacy market. Now the e-commerce giant could be looking to elbow its way into the brick-and-mortar pharmacy market by opening retail pharmacy stores. In this Motley Fool Live video recorded on June 2, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not CVS Health (CVS -0.11%) and Walgreens Boots Alliance (WBA 1.18%) could be in trouble if Amazon competes head-to-head with them.

Keith Speights: Now there's another tech giant that's making waves in healthcare as well, Amazon -- ticker there is AMZN. Business Insider reported last week that Amazon is thinking about jumping into the retail pharmacy market, and not just online pharmacy, but actual stores, retail pharmacies. This news caused the stocks of CVS Health, Walgreens Boots Alliance, both to tumble. Do you think CVS and Walgreens are potentially in trouble if Amazon decides to jump into the retail pharmacy space?

Brian Orelli: I think it probably depends on what strategy Amazon ends up taking and from the article it sounded like they have been pondering this for a while, so they certainly don't seem like they've made up their minds. But if they go to building out stand-alone pharmacies, that route, it will probably take quite a while to be a formidable foe against the larger chains that have hundreds and hundreds of sites. I'm not sure that would really hurt them all that much, certainly not in the near term.

Another option is would be to put the pharmacies within Whole Foods, and now they have a base of a whole bunch of stores, and so that would certainly be faster. It's worked well for CVS. They have mini clinics inside a lot of their stores.

I'm not sure how well it would actually work to build out a spot out of Whole Foods. You're going to end up losing sales for Whole Foods, so you have to factor that in. Is the benefit of having a pharmacy within the Whole Foods going to help, going to result in more profits than the loss of the Whole Foods sales that they could have for that same space. I think the biggest worry for the chains is if Amazon actually acquired another chain.

If they bought, let's say, the Rite Aid, that's probably the smallest of the three. I think if they did that, that would allow them to ramp up really quickly. Obviously, if they just rebranded them as Amazon stores and then they can also integrate package pickups and returns into the store and that will get people into the store. I think that would be the biggest worry for the pharmacy companies.

Speights: Yeah. I would think CVS and Walgreens would probably be able to hold their own but Amazon is a formidable rival in any market it decides to enter. And I think what you're mentioning, Brian, the possibility that they could integrate small pharmacies into Whole Foods stores. That might be the route the company would take, and I think Amazon could be a big player in this retail pharmacy market over the next decade.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Brian Orelli, PhD has no position in any of the stocks mentioned. Keith Speights owns shares of Amazon. The Motley Fool owns shares of and recommends Amazon. The Motley Fool recommends CVS Health and recommends the following options: long January 2022 $1,920 calls on Amazon and short January 2022 $1,940 calls on Amazon. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned, Inc. Stock Quote, Inc.
$143.18 (-0.26%) $0.37
Walgreens Boots Alliance, Inc. Stock Quote
Walgreens Boots Alliance, Inc.
$41.07 (1.18%) $0.48
CVS Health Corporation Stock Quote
CVS Health Corporation
$106.27 (-0.11%) $0.12
Rite Aid Corporation Stock Quote
Rite Aid Corporation
$10.86 (-1.72%) $0.19

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/15/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.